Pilotto Elisabetta

Midena Edoardo, Frizziero Luisa, Midena Giulia, Pilotto Elisabetta

Midena Edoardo, Frizziero Luisa, Midena Giulia, Pilotto Elisabetta

This review found intraocular fluid biomarkers effectively track DR progression and treatment response, offering a precision medicine tool for diabetic eye disease management.

Frizziero Luisa, Parrozzani Raffaele, Londei Davide, Pilotto Elisabetta, Midena Edoardo

Diabetic retinopathy causes distinct peripapillary microvascular and macrovascular changes. Neuronal damage (ganglion cell complex thinning) was observed, but not directly correlated with microvascular changes, suggesting independent mechanisms.

Midena Edoardo, Bini Silvia, Martini Ferdinando, Enrica Convento, Pilotto Elisabetta, Micera Alessandra et al.

Subthreshold micropulse laser for diabetic macular edema improved vision, reduced macular thickness, and decreased Müller cell dysfunction markers (GFAP, Kir 4.1) and VEGF, suggesting it restores Müller cell function.

Parrozzani Raffaele, Clementi Maurizio, Kotsafti Olympia, Miglionico Giacomo, Trevisson Eva, Orlando Gloria et al.

OCT retinal nerve fiber layer analysis proved superior to visual function and optic disc exams for screening optic pathway gliomas in pediatric neurofibromatosis type 1, offering a better screening tool.

Vujosevic Stela, Martini Ferdinando, Cavarzeran Fabiano, Pilotto Elisabetta, Midena Edoardo

This study found choroidal thickness (CT) progressively decreases with increasing diabetic retinopathy severity. This suggests CT reduction is linked to DR progression, highlighting the choroid's potential role in DR pathophysiology.